Literature DB >> 8601370

Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.

K Tajima1, T Katagiri.   

Abstract

A case of hypereosinophilic syndrome with eosinophilic colitis, eosinophilic cholecystitis, and increased serum levels of interleukin-5 (IL-5) and soluble interleukin-2 receptor (sIL-2R) is reported. Immunohistochemical studies of cholecystectomy and colon biopsy specimens with monoclonal antibodies, which are specific for activated eosinophils, secreted eosinophil cationic protein (ECP) and for major basic protein (MBP), demonstrated the presence of numerous activated eosinophils, secretion of ECP, and deposition of MBP in areas of tissue damage. These findings suggest that in eosinophilic cholecystitis and eosinophilic colitis, activated eosinophils infiltrate and degranulate in each tissue, releasing eosinophil granule proteins that produce tissue damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601370     DOI: 10.1007/bf02093816

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Regulatory effect of cytokines on eosinophil degranulation.

Authors:  T Fujisawa; R Abu-Ghazaleh; H Kita; C J Sanderson; G J Gleich
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

2.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation.

Authors:  H Enokihara; S Furusawa; H Nakakubo; H Kajitani; S Nagashima; K Saito; H Shishido; Y Hitoshi; K Takatsu; T Noma
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

4.  Clonal nature of hypereosinophilic syndrome.

Authors:  M Luppi; R Marasca; M Morselli; P Barozzi; G Torelli
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Interleukin 5 activity in sera from patients with eosinophilia.

Authors:  H Enokihara; H Kajitani; S Nagashima; S Tsunogake; N Takano; K Saito; S Furusawa; H Shishido; Y Hitoshi; K Takatsu
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

7.  Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome.

Authors:  P C Tai; M E Holt; P Denny; A R Gibbs; B D Williams; C J Spry
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

8.  Glucocorticoids inhibit cytokine-mediated eosinophil survival.

Authors:  N Wallen; H Kita; D Weiler; G J Gleich
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

9.  Human platelets secrete chemotactic activity for eosinophils.

Authors:  J A Burgers; R C Schweizer; L Koenderman; P L Bruijnzeel; J W Akkerman
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

Review 10.  The interleukin 2 receptor in the hypereosinophilic syndrome.

Authors:  J Plumas; V Gruart; M Capron; A Capron; L Prin
Journal:  Leuk Lymphoma       Date:  1992-12
View more
  8 in total

1.  A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma.

Authors:  Yosuke Aihara; Hitoshi Yoshiji; Masaharu Yamazaki; Yasuhide Ikenaka; Ryuichi Noguchi; Chie Morioka; Kosuke Kaji; Haruki Tastumi; Keisuke Nakanishi; Maiko Nakamura; Junichi Yamao; Masahisa Toyohara; Akira Mitoro; Masayoshi Sawai; Motoyuki Yoshida; Masao Fujimoto; Masahito Uemura; Hiroshi Fukui
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

2.  Marked infiltration of eosinophils in necrotizing granulomas in the resected hepatic bed after cholecystectomy resulting from gallbladder cancer and metastatic liver cancer is associated with peculiar peripheral eosinophilia.

Authors:  Yuji Ohtsuki; Masashi Kimura; Ryohei Watanabe; Yuhei Okada; Yuki Teratani; Atsushi Kurabayashi; Tamotsu Takeuchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

3.  Biliary tract disease: a rare manifestation of eosinophilic gastroenteritis.

Authors:  Manuel Jimenez-Saenz; Jose Luis Villar-Rodriguez; Yolanda Torres; Isabel Carmona; Ernesto Salas-Herrero; Jesus Gonzalez-Vilches; Juan M Herrerias-Gutierrez
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

Review 4.  Eosinophilic gastroenteritis: a review.

Authors:  Nahum Méndez-Sánchez; Norberto C Chávez-Tapia; Genaro Vazquez-Elizondo; Misael Uribe
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

5.  Clinicopathological Study of Eosinophilic Cholecystitis: Five Year Single Institution Experience.

Authors:  Sabina Khan; Mohammad Jaseem Hassan; Zeeba Shamim Jairajpuri; Sujata Jetley; Musharraf Husain
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 6.  Diagnosing eosinophilic colitis: histopathological pattern or nosological entity?

Authors:  Alan W H Bates
Journal:  Scientifica (Cairo)       Date:  2013-05-09

7.  Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Hiroyuki Ito; Yusuke Mishima; Tsubomi Cho; Naoki Ogiwara; Yoshimasa Shinma; Masashi Yokota; Kazuya Anzai; Shingo Tsuda; Junko Nagata; Seiichiro Kojima; Noriko Sasaki; Takayuki Wakabayashi; Norihito Watanabe; Takayoshi Suzuki
Journal:  Case Rep Gastroenterol       Date:  2020-12-11

8.  Peripheral eosinophilia - is it a predictable factor associated with eosinophilic cholecystitis?

Authors:  Seung-Seop Yeom; Ho-Hyun Kim; Jung-Chul Kim; Young-Hoe Hur; Yang-Seok Koh; Chol-Kyoon Cho; Hyun-Jong Kim; Sang-Soo Shin; Hyung-Seok Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.